Lunacalcipol(250384-82-8)
- Name: Lunacalcipol
- Synonyms:Lunacalcipol;CTA018;250384-82-8;CTA-018;UNII-XN4TL6M50Z;Lunacalcipol [USAN];Lunacalcipol [USAN:INN];XN4TL6M50Z;CTA 018;(1R,3S,5Z)-5-[(2E)-2-[(3aS,7aS)-1-[(E,2R)-5-tert-butylsulfonylpent-4-en-2-yl]-7a-methyl-3a,5,6,7-tetrahydro-3H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol;(5Z,7E,16Z,23E)-(1S,3R)-25-nor-25-t-Butylsulfonyl-9,10-seco-5,7,10(19),16,23- cholestapentaene-1,3-diol;1,3-Cyclohexanediol, 5-((2E)-2-((3aS,7aS)-1-((1R,3E)-4-((1,1-dimethylethyl)sulfonyl)-1- methyl-3-buten-1-yl)-3,3a,5,6,7,7a-hexahydro-7a-methyl-4H-inden-4- ylidene)ethylidene)-4-methylene-, (1R,3S,5Z)-;Lunacalcipol (USAN/INN);LUNACALCIPOL [INN];D00DYK;LUNACALCIPOL [WHO-DD];CHEMBL2105705;GTPL11382;CHEBI:177662;CTA018/MT2832;BDBM50023361;AKOS040752736;MT-2832;D09928;Q27293916;Lunacalcipol (intravenous, secondary hyperparathyroidism);CTA-018 (intravenous, secondary hyperparathyroidism), Cytochroma;Lunacalcipol (intravenous, secondary hyperparathyroidism), Cytochroma;CYP24 inhibitors (intravenous, secondary hyperparathyroidism), Johns Hopkins/Cytochroma;(1R,3S,5Z)-5-[(2E)-2-[(3aS,7aS)-1-[(E,2R)-5-tert-butylsulonylpent-4-en-2-yl]-7a-methyl-3a,5,6,7-tetrahydro-3H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol;(5Z,7E,16Z,23E)-24-((1,1-Dimethylethyl)sulfonyl)-9,10-secochola-5,7,10(19),16,23- pentaene-1alpha,3beta-diol
- Molecular Formula:C28H42O4S
- Molecular Weight:474.7
- CAS Registry Number:250384-82-8
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 250682-46-3/(3S)-8-Methyl-3-(tert-butoxycarbonylamino)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-5-acetic acid
- 26803-65-6/1,2,3,4-Tetrahydro-8-hydroxy-7-methoxy-2-(2,2,2-trifluoroacetyl)spiro[5H-2-benzazepine-5,1'-[2,5]cyclohexadien]-4'-one
- 186789-49-1/1,3,5-Tris(2,2,2-trifluoroethyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-triimine
- 212911-06-3/Alantrypinone
- 219814-37-6/1-Methyl-1-[[(2R)-5-(1,2-dihydroxyethyl)-5beta-(hydroxymethyl)tetrahydrofuran]-2beta-yl]ethyl beta-D-glucopyranoside
- 269075-59-4/(3-Amino-1-(methylsulfonyl)-1H-indol-2-yl)(4-bromophenyl)methanone
- 197894-85-2/(3R)-1-Phenyl-3-(4-pyridinylcarbonylamino)-9-amino-3,4,6,7-tetrahydropyrrolo[3,2,1-jk][1,4]benzodiazepine-4-one
- 163380-26-5/(3R,4S)-3-[(S)-3-Hydroxy-3-phenylpropyl]-1-(4-methoxyphenyl)-4-(4-hydroxyphenyl)-2-azetidinone
- 792893-10-8/N-(4-Amino-quinolin-6-yl)-2-(4-chloro-phenoxymethyl)-benzamide
- 255833-56-8/Lepidiumterpenoid
- 771465-41-9/N-(1-Amino-3-methyl-isoquinolin-7-yl)-2-(4-chloro-phenoxymethyl)-benzamide
- 4178-45-4/Dulxanthone C
- 216387-14-3/Acetamide, N-(2-(4-hydroxy-7H-pyrido(2,3,4-kl)acridin-6-yl)ethyl)-
- 183589-33-5/Phenyl[2-phenyl-3-(3,3,5,5-tetramethyl-1-cyclohexen-1-yl)-5-benzofuranyl]methanone
- 211486-16-7/6-Oxo-5,9-epidioxy-5alpha-ergosta-7,22-diene-3beta-ol
- 211486-11-2/(22E)-5alpha,8alpha-Epidioxy-23-methylergosta-6,22-dien-3beta-ol
- 211486-15-6/(22E)-Ergosta-7,22-diene-3beta,5alpha,6alpha,9alpha-tetrol
- 191848-32-5/N-Desmethyl ruboxistaurin
- 236403-28-4/(3R)-1,2,3,4-Tetrahydro-2-[[3-[(2-hydroxybenzoyl)amino]phenyl]sulfonyl]isoquinoline-3-carbohydroxamic acid
- 250384-82-8/Lunacalcipol
- 175923-64-5/Khelmarin D
- 220381-48-6/Coagulin M
- 344362-49-8/Pseudoceratine A
- 186824-60-2/Artonol D
- 267649-96-7/Lanosta-8,25-dien-21-oic acid, 3-(acetyloxy)-24-hydroxy-, (3alpha)-
- 201274-89-7/5,8-Diphenyl-3-benzyl-7-methyl-5,8-dihydrospiro[1,4-dithia-3,5,6-tri-aza-s-indacene-2(3H),1'-cyclohexane]
- 172616-90-9/25-O-cinnamoylvulgaroside
- 172616-89-6/24-O-acetyl-25-O-cinnamoylvulgaroside
- 220381-51-1/Coagulin N
- 227179-08-0/(22R)-1alpha-Acetoxy-3beta-(beta-D-glucopyranosyloxy)-22,27-dihydroxyergosta-5,24-diene-26-oic acid delta-lactone